Compare Cassava Sciences Inc (FLNA) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Invesco S&P 500 High Div Low Volatility ETF trades at $53.04. The key difference: Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SPHD | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | — |
52-Week High | $4.64 | $52.63 |
52-Week Low | $1.09 | $46.96 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
The Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) trades at $52.91, up 1.79% today, with a bullish technical signal from moving averages. The fund focuses on high-dividend, low-volatility S&P 500 stocks, offering a 4.5% 30-day SEC yield with monthly distributions. Recent news highlights its appeal to retirees seeking reliable income, though performance has trailed the broader S&P 500 historically.
SPHD presents a defensive income opportunity amid market uncertainty, with portfolio shifts toward energy, consumer staples, and financials enhancing resilience. Key risks include underperformance during strong bull markets and interest rate sensitivity. Analyst sentiment is cautiously positive, with Seeking Alpha upgrading to Buy in May 2026 for its defensive positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
